Alaa Elmetwalli
Tabuk, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Unveiling the inhibitory effects of tannic acid and doxorubicin combination on pyruvate kinase M2 in breast cancer cells.
Journal: Frontiers in pharmacology
Published: February 27, 2026
Polysaccharide-stabilized biogenic CuO/SeO2 nanocomposites: green synthesis, physicochemical characterization, and enhanced antioxidant, antimicrobial, and selective anticancer activities.
Journal: RSC advances
Published: January 21, 2026
Diagnostic value of integrated albumin-to-leukocyte ratio risk modeling stratification and machine learning approaches for prediction of spontaneous bacterial peritonitis in cirrhotic patients.
Journal: BMC infectious diseases
Published: December 20, 2025
Mechanistic Insights into Honey-Mediated Antibacterial Activity Against Enterobacteriaceae: A Multifaceted Approach Targeting Membrane Integrity, Protein Synthesis, and Quorum Sensing Inhibition.
Journal: Probiotics and antimicrobial proteins
Published: December 12, 2025
SUMO3/RUNX1/AIRE/RCAN1 and DNMT3L/DYRK1A/Let-7c-5p/VEGF axes: immune dysregulation and genetic susceptibility as pulmonary risk factors in Down syndrome.
Journal: 3 Biotech
Published: November 01, 2025
Ferroptosis and the cGAS-STING pathway into precision nano-immuno-theranostics: A mechanistic paradigm for reversing drug resistance in hepatocellular carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 20, 2025
Risk stratification of spontaneous bacterial peritonitis recurrence: integrating acute kidney injury, biomarkers, composite scores, and machine learning models.
Journal: Gut pathogens
Published: July 27, 2025
Molecular docking insights into miR-155 and VEGF synergy: colorectal cancer detection through AI-enhanced integration of molecular biomarkers and clinical risk assessment.
Journal: European journal of medical research
Published: July 13, 2025
Precision tumor targeting: gamma-irradiated ellagic acid therapy for ferroptosis and necroptosis modulation via GPX4/ALOX/RIPK/MLKL pathway inhibition.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 08, 2025
Last Updated: 09/26/2026